IL319556A - Process for creating hyaluronic acid conjugates and hyaluronic acid conjugates formed - Google Patents
Process for creating hyaluronic acid conjugates and hyaluronic acid conjugates formedInfo
- Publication number
- IL319556A IL319556A IL319556A IL31955625A IL319556A IL 319556 A IL319556 A IL 319556A IL 319556 A IL319556 A IL 319556A IL 31955625 A IL31955625 A IL 31955625A IL 319556 A IL319556 A IL 319556A
- Authority
- IL
- Israel
- Prior art keywords
- hyaluronic acid
- conjugates
- conjugation
- hyaluronic
- acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/549—Sugars, nucleosides, nucleotides or nucleic acids
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction, e.g. ion-exchange, ion-pair, ion-suppression or ion-exclusion
- B01D15/361—Ion-exchange
- B01D15/362—Cation-exchange
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
- B01D61/24—Dialysis ; Membrane extraction
- B01D61/243—Dialysis
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0003—General processes for their isolation or fractionation, e.g. purification or extraction from biomass
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Polymers & Plastics (AREA)
- Materials Engineering (AREA)
- Pharmacology & Pharmacy (AREA)
- Analytical Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Sustainable Development (AREA)
- Epidemiology (AREA)
- Water Supply & Treatment (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Materials For Medical Uses (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT102022000018585A IT202200018585A1 (it) | 2022-09-12 | 2022-09-12 | Procedimento di coniugazione dell’acido ialuronico e coniugati dell’acido ialuronico così ottenuti |
| PCT/IB2023/058903 WO2024057154A1 (en) | 2022-09-12 | 2023-09-08 | Process for conjugation of hyaluronic acid and conjugates of hyaluronic acid so obtained |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL319556A true IL319556A (en) | 2025-05-01 |
Family
ID=84943683
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL319556A IL319556A (en) | 2022-09-12 | 2023-09-08 | Process for creating hyaluronic acid conjugates and hyaluronic acid conjugates formed |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP4587481A1 (de) |
| JP (1) | JP2025528605A (de) |
| KR (1) | KR20250067823A (de) |
| CN (1) | CN119855838A (de) |
| CA (1) | CA3267508A1 (de) |
| IL (1) | IL319556A (de) |
| IT (1) | IT202200018585A1 (de) |
| WO (1) | WO2024057154A1 (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN119548996B (zh) * | 2024-12-04 | 2025-11-04 | 万华化学集团股份有限公司 | 一种反渗透元件修复方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3397651B1 (de) * | 2015-12-29 | 2020-05-06 | Galderma S.A. | Kohlenhydratvernetzer |
| WO2020129028A1 (en) * | 2018-12-21 | 2020-06-25 | Nestlé Skin Health S.A. | Hydrogel compositions encapsulating solid particles |
-
2022
- 2022-09-12 IT IT102022000018585A patent/IT202200018585A1/it unknown
-
2023
- 2023-09-08 JP JP2025538901A patent/JP2025528605A/ja active Pending
- 2023-09-08 CA CA3267508A patent/CA3267508A1/en active Pending
- 2023-09-08 IL IL319556A patent/IL319556A/en unknown
- 2023-09-08 CN CN202380065710.XA patent/CN119855838A/zh active Pending
- 2023-09-08 WO PCT/IB2023/058903 patent/WO2024057154A1/en not_active Ceased
- 2023-09-08 KR KR1020257008394A patent/KR20250067823A/ko active Pending
- 2023-09-08 EP EP23783022.9A patent/EP4587481A1/de active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| IT202200018585A1 (it) | 2024-03-12 |
| EP4587481A1 (de) | 2025-07-23 |
| CA3267508A1 (en) | 2024-03-21 |
| KR20250067823A (ko) | 2025-05-15 |
| WO2024057154A1 (en) | 2024-03-21 |
| JP2025528605A (ja) | 2025-08-28 |
| CN119855838A (zh) | 2025-04-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL319556A (en) | Process for creating hyaluronic acid conjugates and hyaluronic acid conjugates formed | |
| MY173940A (en) | Process for producing pyrrole compound | |
| PH12014500791A1 (en) | Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydromorphone, prodrugs, methods of making and use thereof | |
| PH12021550930A1 (en) | Drug Antibody Conjugates | |
| GB202007924D0 (en) | Modified strains of chlorella vulgaris and method of production | |
| EP4101860A4 (de) | Hyaluronsäurederivate, pharmazeutische zusammensetzung und hyaluronsäurederivat-wirkstoffkonjugat | |
| CA3261605A1 (en) | METHODS FOR IN VIVO EDITING OF KLKB1 | |
| IL316963A (en) | Process for preparing avalopretide | |
| FI4135773T3 (fi) | Menetelmä hyaluronihapon ja paklitakselin konjugaatin synteesiin | |
| MX2024003127A (es) | Inhibidores de fabp4/5, metodos de uso y metodos de elaboración. | |
| EP4271428A4 (de) | Injizierbare photovernetzte hyaluronsäurehydrogele, herstellungsverfahren dafür und deren verwendung zur behandlung von osteoarthritis | |
| MX2022015522A (es) | Proceso para la elaboracion de alquilamidotiazoles. | |
| WO2021216687A9 (en) | Peptides for the treatment of covid-19 | |
| MX2024004222A (es) | Conjugados anticuerpo-farmaco y metodos para fabricar los mismos. | |
| CA3262222A1 (en) | AUF1 Gene Therapy for Limb-Bridge Myopathy | |
| IL317424A (en) | Sialic acid derivatives and methods of using them | |
| IL316020A (en) | Conjugations of antidote drugs based on arbolin and methods of use | |
| IL321621A (en) | Methods for preparing antibody-polynucleotide conjugates | |
| HK40104922A (en) | Preparation of hyaluronic acid cbd conjugates | |
| CA3277800A1 (en) | Methods of preparing antibody-polynucleotide conjugates | |
| GB202502430D0 (en) | Novel comounds and drug conjugates | |
| WO2019088800A3 (ko) | 폴리에틸렌글리콜 유도체 및 이의 제조방법 | |
| GB202507302D0 (en) | Novel in vitro method | |
| IL316912A (en) | Antibody-drug conjugates target B7-H4 for cancer treatment | |
| GB202210858D0 (en) | Method to produce novel amino acid |